Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GreenGene F Extension Study in Severe Hemophilia A
NCT02027779Phase 3Unknown
- Sponsor
- GC Biopharma
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of GreenGene F in hemophilia A, sponsored by GC Biopharma. Status: unknown.
02
Drugs
GreenGene F
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02027779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027779.